StockData
Jazz Pharmaceuticals plc logo

Jazz Pharmaceuticals plc (JAZZ) stock

JAZZNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 7/30122% above fair value
$240.71+0.94 (+0.39%)

Close on Nov 17, 2026Market cap $15.63BP/E 78.4Yield –

Jazz Pharmaceuticals total assets

Total assets on the balance sheet at the end of each period.

Jazz Pharmaceuticals's total assets was $12.00B at Sep 30, 2026. For fiscal 2025 it was $11.66B, down 2.9% from the year before. Over ten years it grew 13.3% a year on average. The highest annual figure on record is $12.30B in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$11.66B-2.9%
FY2024Dec 31, 2024$12.01B+5.4%
FY2023Dec 31, 2023$11.39B+5.2%
FY2022Dec 31, 2022$10.84B-11.9%
FY2021Dec 31, 2021$12.30B+88.2%
FY2020Dec 31, 2020$6.54B+18.0%
FY2019Dec 31, 2019$5.54B+6.4%
FY2018Dec 31, 2018$5.20B+1.6%
FY2017Dec 31, 2017$5.12B+6.7%
FY2016Dec 31, 2016$4.80B+44.0%
FY2015Dec 31, 2015$3.33B-0.2%
FY2014Dec 31, 2014$3.34B+49.2%
FY2013Dec 31, 2013$2.24B+13.8%
FY2012Dec 31, 2012$1.97B+675.5%
FY2011Dec 31, 2011$253.57M+86.8%
FY2010Dec 31, 2010$135.73M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$12.00B+5.6%
Q2 FY2026Jun 30, 2026$11.08B+1.2%
Q1 FY2026Mar 31, 2026$11.86B+2.8%
Q4 FY2025Dec 31, 2025$11.66B-2.9%
Q3 FY2025Sep 30, 2025$11.36B-7.3%
Q2 FY2025Jun 30, 2025$10.94B-3.7%
Q1 FY2025Mar 31, 2025$11.53B+1.8%
Q4 FY2024Dec 31, 2024$12.01B+5.4%
Q3 FY2024Sep 30, 2024$12.26B+9.4%
Q2 FY2024Jun 30, 2024$11.36B+0.9%
Q1 FY2024Mar 31, 2024$11.33B+2.5%
Q4 FY2023Dec 31, 2023$11.39B+5.2%
Q3 FY2023Sep 30, 2023$11.20B+7.9%
Q2 FY2023Jun 30, 2023$11.26B+0.5%
Q1 FY2023Mar 31, 2023$11.05B-6.1%
Q4 FY2022Dec 31, 2022$10.84B-11.9%
Q3 FY2022Sep 30, 2022$10.38B-16.8%
Q2 FY2022Jun 30, 2022$11.20B-15.2%
Q1 FY2022Mar 31, 2022$11.77B+74.2%
Q4 FY2021Dec 31, 2021$12.30B+88.2%
Q3 FY2021Sep 30, 2021$12.48B+98.3%
Q2 FY2021Jun 30, 2021$13.21B+117.8%
Q1 FY2021Mar 31, 2021$6.76B+29.6%
Q4 FY2020Dec 31, 2020$6.54B+18.0%
Q3 FY2020Sep 30, 2020$6.29B+13.8%
Q2 FY2020Jun 30, 2020$6.07B+10.5%
Q1 FY2020Mar 31, 2020$5.22B-1.2%
Q4 FY2019Dec 31, 2019$5.54B+6.4%
Q3 FY2019Sep 30, 2019$5.53B+0.8%
Q2 FY2019Jun 30, 2019$5.49B+2.6%
Q1 FY2019Mar 31, 2019$5.28B-0.1%
Q4 FY2018Dec 31, 2018$5.20B+1.6%
Q3 FY2018Sep 30, 2018$5.49B+9.7%
Q2 FY2018Jun 30, 2018$5.35B+11.3%
Q1 FY2018Mar 31, 2018$5.29B+9.8%
Q4 FY2017Dec 31, 2017$5.12B+6.7%
Q3 FY2017Sep 30, 2017$5.00B–
Q2 FY2017Jun 30, 2017$4.80B–
Q1 FY2017Mar 31, 2017$4.82B–
Q4 FY2016Dec 31, 2016$4.80B–

More Jazz Pharmaceuticals figures

See a number that looks wrong?